Now accepting a limited number of new Valerian patients each quarter · River Oaks, Houston
Reserve Your AssessmentThis is how stem cells are applied to joint and mobility work at Valere, delivered under imaging, inside a program that addresses the biology surrounding the joint, not only the joint itself.
A joint does not fail on its own. Cartilage thins in an environment, one shaped by inflammatory load, hormonal status, metabolic health, and how efficiently your tissue can still repair itself. Most Valerian patients arrive having had the joint examined and everything around it ignored.
They have done physical therapy. They have had cortisone, which reduces inflammation temporarily while doing nothing for the tissue underneath. They have been told the next conversation is replacement, and they are not ready to have it.
What has not happened is a physician looking at the joint and the bloodwork together. That is where this program starts, and it is why joint work at Valere runs alongside hormone optimization and peptide support rather than in isolation from them.
Knees
Cartilage wear, stiffness on stairs, morning pain, and the loss of confidence in the joint under load.
Shoulders
Rotator cuff changes, restricted overhead range, and the old injury that never fully resolved.
Hips & Spine
Degenerative change affecting gait, sleep position, and how far you are willing to walk without thinking about it.
The Biology Around Them
Systemic inflammation, hormonal status, and metabolic function, assessed in the same panel, because they determine what the tissue can do with any intervention.
Order matters here. Cells delivered into an inflamed, hormonally depleted joint environment have less to work with than the same cells delivered after that environment has been corrected.
Existing MRI or X-ray reviewed, new imaging ordered where needed, and a comprehensive panel covering inflammatory markers, hormones, and metabolic function. Structure and biology assessed together rather than separately.
Where the panel shows elevated inflammatory burden or suboptimal hormonal status, those are addressed first. This is the step most practices omit, and it is frequently the difference between a result that holds and one that fades.
Cellular preparations placed at the anatomical target under real-time imaging, with position confirmed rather than estimated by landmark. Outpatient, no general anesthesia, typically twenty-four to forty-eight hours of reduced activity.
Structured progressive loading built around what the joint can currently support, panels at six to eight weeks, and coaching between appointments. Tissue responds to demand. The program is designed to give it the right amount.
Cellular therapies applied in this program are investigational and are not approved by the FDA for the treatment of osteoarthritis or any other condition. Published research on mesenchymal stem cell therapy for knee osteoarthritis is reviewed at PubMed (PMID 32913710); findings across trials are mixed and candidacy is determined by the physician following evaluation.
Two joint programs can use the same word and deliver materially different things. The difference is set by how the cells were cultured and where they were sourced. Decisions made before anything reaches the practice.
Cells grown flat against plastic adopt a shape they never take in the body. Cultured in three dimensions they form spheroids: clustered aggregates closer to how cells organize in living tissue. A manufacturing distinction, and one most practices never mention.
AATB-accredited, FDA-registered tissue establishments operating under current Good Tissue Practices. Every lot carries independently verified documentation covering viability, identity, sterility, endotoxin, and mycoplasma.
Delivery is performed under real-time imaging. Anatomical landmarks are an estimate; imaging is verification. For an intra-articular target, that distinction determines whether the preparation reaches the tissue at all.
Nutrition, exercise, coaching, hormone optimization, peptide support, and supplement support are assessed alongside the joint work. The environment determines the result. That is not an add-on here. It is the program.
Not necessarily, and a surgical recommendation from one physician is not the final determination of your options. Regenerative approaches address different mechanisms than surgery does. What the assessment provides is a complete picture of imaging plus bloodwork, so you can make an informed decision rather than accept a single opinion as the only one available. Where replacement is clearly indicated, your physician will tell you that directly. This is not a substitute for surgical care when surgery is warranted.
Two differences. The first is what is delivered: cellular preparations that signal repair rather than corticosteroid, which reduces inflammation temporarily while doing nothing for the tissue beneath it. The second is what surrounds the delivery. Most injections are a standalone event. Here the injection sits inside a program that corrects the inflammatory and hormonal environment first, then loads the joint progressively afterward. The injection is one stage of four.
The honest answer is that the evidence is developing and mixed. Meta-analyses of randomized trials in knee osteoarthritis have reported improvement in pain and function scores, while other analyses have found results comparable to placebo, and recent work has examined how much of the effect is contextual. That literature is available at PubMed. What your physician will do at assessment is tell you where your specific clinical picture sits relative to that evidence, including if you are not a good candidate. Anyone promising you certainty in this space is selling something.
Typically twenty-four to forty-eight hours of reduced activity at the treated site. It is an outpatient procedure with no general anesthesia. This varies by joint, by the specifics of your case, and by individual response, and your physician outlines the expectation before anything is scheduled. Compare that to three to six months of rehabilitation following joint replacement, with full functional recovery often extending toward a year.
Because the joint is not sealed off from the rest of you. Systemic inflammatory burden, hormonal status, insulin sensitivity, and nutritional inputs all shape how efficiently tissue repairs itself. A joint sitting in a poor environment will underperform regardless of what is delivered into it. That is why hormone optimization and peptide support frequently run alongside joint work rather than after it, and why nutrition, exercise, and coaching are part of the same program.
No. Valere operates as a private-pay practice. Regenerative programs are not covered by standard insurance, which is what allows the program to be built around what is clinically right for you rather than what is reimbursable. The depth of the panel, the imaging, the physician time, and the ongoing coaching are not possible inside an insurance-driven model. Payment plans and membership options are available.
Your assessment covers imaging and a comprehensive panel. Your physician reviews both with you and tells you honestly whether this program is the right one.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston